Physician Assistant, Medical · Boise, ID
NPI
1265464036
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
403 South 11th St, Ste 100
Boise, ID, 83702
Phone (208) 429-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
296 services
Medicare patients, 2024
76
Average age 69
Drug cost, 2024
$836K
2,072 prescriptions
Company payments, 2025
$4,882
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharene E Watsen was code 99214 (office e&m - established), 169 times for 66 patients. In total Sharene E Watsen billed 296 services in 6 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 169 | 66 | $52.38 | $8,852 |
| 95251 Test - Miscellaneous | Office | 99 | 41 | $19.37 | $1,918 |
| 99213 Office E&M - Established | Office | 20 | 14 | $35.68 | $714 |
By year: 2022 $11K for 260 services; 2023 $12K for 288 services; 2024 $12K for 296 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharene E Watsen prescribed most often to Medicare patients was Levothyroxine Sodium, with 208 prescriptions and refills. In total Sharene E Watsen wrote 2,072 Medicare prescriptions that cost $836K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 208 | 564 | 56 | $2,378 |
| Atorvastatin Calcium Generic | 121 | 345 | 36 | $1,144 |
| Ozempic Semaglutide | 109 | 147 | 17 | $129K |
| Trulicity Dulaglutide | 66 | 88 | Under 11 | $85K |
| Metformin Hcl Er Metformin Hcl | 65 | 192 | 19 | $1,058 |
| Rosuvastatin Calcium Generic | 61 | 177 | 18 | $903 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 46 | 67 | Under 11 | $3,894 |
| Tresiba Flextouch U-100 Insulin Degludec | 46 | 114 | 14 | $20K |
| Ezetimibe Generic | 45 | 139 | 15 | $980 |
| Humalog Insulin Lispro | 45 | 115 | 12 | $16K |
| Lisinopril Generic | 42 | 126 | 13 | $249 |
| Insulin Lispro Generic | 41 | 100 | 14 | $5,921 |
| Farxiga Dapagliflozin Propanediol | 38 | 84 | Under 11 | $45K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 38 | 75 | 12 | $26K |
| Synthroid Levothyroxine Sodium | 37 | 107 | 11 | $2,368 |
Brand drugs: 1,019 claims; generic drugs: 865 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharene E Watsen $4,882 ($4,882 in general payments such as food, travel and fees) from 5 companies. The largest payer was Insulet Corporation with $2,551.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.